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Abstract
Aims/hypothesis Gait characteristics and balance are altered
in diabetic patients. Little is known about possible
treatment strategies. This study evaluates the effect of a
specific training programme on gait and balance of diabetic
patients.
Methods This was a randomised controlled trial (n=71)
with an intervention (n=35) and control group (n=36). The
intervention consisted of physiotherapeutic group training
including gait and balance exercises with function-
orientated strengthening (twice weekly over 12 weeks).
Controls received no treatment. Individuals were allocated
to the groups in a central office. Gait, balance, fear of falls,
muscle strength and joint mobility were measured at
baseline, after intervention and at 6-month follow-up.
Results The trial is closed to recruitment and follow-up.
After training, the intervention group increased habitual
walking speed by 0.149 m/s (p<0.001) compared with the
control group. Patients in the intervention group also
significantly improved their balance (time to walk over a
beam, balance index recorded on Biodex balance system),
their performance-oriented mobility, their degree of concern
about falling, their hip and ankle plantar flexor strength, and
their hip flexion mobility compared with the control group.
After6months,allthesevariablesremainedsignificantexcept
for the Biodex sway index and ankle plantar flexor strength.
Two patients developed pain in their Achilles tendon: the
progression for two related exercises was slowed down.
Conclusions/interpretation Specific training can improve
gait speed, balance, muscle strength and joint mobility in
diabetic patients. Further studies are needed to explore the
influence of these improvements on the number of reported
falls, patients’ physical activity levels and quality of life.
Trial registration: ClinicalTrials.gov NCT00637546
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Introduction
Type 2 diabetes mellitus and its common complication,
peripheral neuropathy, affect a large population [1, 2].
Peripheral neuropathy leads to sensory and motor deficits,
which often result in mobility-related dysfunction, alter-
ations in gait characteristics [3, 4] and balance impairments
[5, 6]. Diabetic patients with peripheral neuropathy have
lower gait velocity, decreased cadence, shorter stride length,
increased stance time and higher step to step variability
compared with healthy controls [3]. These gait alterations
increase on irregular surfaces [3]. Moreover, these patients
have less ankle moment and ankle power [7, 8], as well as a
different onset and cessation time of muscle activity
compared with healthy controls [7]. Patients present more
co-contractions of agonist and antagonist muscles at the
ankle and knee joints during stance phase. Kwon et al. [7]
speculate that the co-contraction mechanism may enable
these individuals to adopt a safer, more stable gait pattern to
compensate for diminished sensory information. The same
authors have reported reduced ankle strength and mobility,
which they considered to be the primary factors contribut-
ing to gait alterations. Allet et al. [3] have also found lower
limb strength, fear of falling and sensory problems to be
related to spatiotemporal gait alterations. Additionally,
individuals with peripheral neuropathy show postural
instability with a larger centre of pressure displacement
[9], higher sway area [10] and greater instability [11] when
standing still with eyes closed [9]. Postural instability was
further found to be significantly associated with sensory
neuropathy [12]. In addition to these gait and balance
impairments, diabetic patients are known to suffer from
increased risk of injurious falls [13]. Fall-related injuries are
often assumed to trigger a vicious circle because of their
potentially detrimental influence on the physical activity
levels of affected patients. Public Health guidelines for
diabetes management recommend that patients perform at
least 30 min of physical activity a day six times a week,
requiring adequate gait security and balance. However, little
is known about treatment strategies that could improve
patients’ gait and balance, thereby also reducing the risk of
falls [4]. Although there is evidence that an exercise
regimen improves clinical measures of balance in patients
with peripheral neuropathy [14], clinical trials investigating
the gait of diabetic individuals generally focus on increased
foot pressure, another major problem in this population and
related to the high risk of ulcers in such patients [15]. Only
few studies have evaluated treatments that aim to improve
gait and balance and decrease fall risk [16, 17]. Petrofsky et
al. [16] tested an insulin sensitiser, rosiglitazone, which
promises to reverse some of the circulatory impairments
seen in diabetes, thereby improving patients’ gait. They
reported encouraging results after administering rosiglita-
zone (decreased step width, reduced reaction time and less
acceleration at the joints). However, rosiglitazone was
recently associated with increased risk of myocardial
infarction and death from cardiovascular incidents [18].
Richardson et al. [17], evaluating patients with various
form of peripheral neuropathy (30 of 42 of whom had
diabetic peripheral neuropathy), found that the use of a cane,
ankle orthoses or touching a wall improved step-width
range, step-time variability and speed while walking under
challenging conditions. To the best of our knowledge, only
Tsang et al. [19] and Orr et al. [20] have investigated the
effect of a specific physical training programme not only on
the activity level and quality of life of diabetic patients, but
also on their habitual and maximal walking speed.
However, both studies seem to have evaluated the same
group of participants. In these studies, the effect of a ‘Tai
Chi for Diabetes’ programme (twice a week for 16 weeks)
on gait, balance, musculoskeletal and cardiovascular fit-
ness, self-reported activity and quality of life was compared
with that of sham exercises. Gait speed and balance
improved, but no significant differences between groups
were reported. Nevertheless, several studies [21–23] have
shown positive training effects on gait speed, postural
stability and mobility of elderly individuals. Additionally, a
meta-analysis [24] evaluating fall prevention studies for the
elderly showed a 4% decrease in the fall-rate of individuals
who were in a treatment group. Since elderly people often
show symptoms similar to those in diabetic patients (i.e. de-
conditioning, muscle weakness, decreased joint mobility and
decreased foot sensibility), we assumed that programmes
developed for the elderly might also improve gait and
balance of diabetic patients. Thus, this study aimed to
evaluate the effect of a specific training programme, which
was based on previously elaborated core components of
successful fall prevention programmes for the elderly [25],
on the gait and balance of diabetic patients.
Gait speed and coefficient of variation of gait cycle time
(CVGCT) were selected as primary outcomes because they
have been shown to be related to increased risk of falls [22,
26] (slow gait speed and high CVGCT indicate increased
fall risk). Balance control, muscle strength and joint
mobility are also important fall risk factors that may be
influenced by exercise [27]. For these reasons, they were
chosen as secondary outcomes. Fear of falls is a cognitive
behavioural component, which was recently shown to be
related to the gait velocity of diabetic patients [28]. It
therefore completed our outcome list.
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training programme would significantly improve their
walking speed and gait variability (CVGCT). We further
assumed that such patients would significantly: (1) improve
their balance; (2) increase their lower limb strength (in
particular hip extensors, knee extensors and ankle flexors);
(3) increase their ankle joint mobility; and (4) decrease their
fear of falling.
Methods
Study design This randomised controlled prospective trial
with two arms (intervention group and control group) was
conducted at the University Hospital of Geneva, Switzer-
land. The study was approved by the local Ethics
Committee.
A sample of 71 diabetic patients was recruited from
patients consulting either the Service of Therapeutic
Education for Chronic Diseases or the Service of Endocri-
nology at the University Hospital in Geneva. Of these, 35
patients were allocated to the intervention group and 36 to
the control group. Patients were included if they were
medically diagnosed with type 2 diabetes (fasting blood
sugar ≥7 mmol/l). Only patients without medical contra-
indications for engaging in physical activity and with a
clinically diagnosed neuropathy were enrolled. Clinically
diagnosed neuropathy was evaluated on the basis of a
vibration perception threshold of ≤4 with a Rydel–Seiffer
tuning fork [29]. Patients were requested to indicate when
they could no longer feel the vibration. At this point the
investigator rated the vibration on a 9-point scale (0=severe
neuropathy; 8=no neuropathy). Exclusion criteria were:
patients with concomitant foot ulcers, orthopaedic or
surgical problems affecting gait variables, non-diabetic
neuropathy (due to Charcot–Marie–Tooth disease or alco-
hol), other neurological pathologies (other than peripheral
neuropathy) that could influence gait variables or inability
to walk a minimum of 500 m without a walking aid.
Training programmes started as soon as enough patients
(20 to 28 per group) had been recruited, i.e. in September
2007, January 2008 and April 2008. For each of these
starting points a new randomisation list was electronically
generated and was used by a person not involved in the
recruitment, evaluation or treatment processes. Each list
ensured equal distribution over groups.
All eligible patients identified by the medical staff were
asked to participate. They were informed that if willing to
participate, they would be randomly assigned to an
intervention group or control group. Patients who agreed
to join the study were contacted by the study coordinator
for an individual appointment, at which the informed
consent document was signed and baseline evaluation
performed. After this initial appointment, during which
patients underwent a clinical examination, a gait analysis
and both static and dynamic balance tests, and also filled in
a fear of falls questionnaire, patients were randomly
allocated to the intervention group or to the control group.
The allocation was accomplished by a secretary in a central
office. All outcome measures were assessed at baseline,
after 12 weeks and after 6 months by the same experienced
physiotherapist each time.
Patients allocated to the intervention group received a
timetable containing all planned sessions over 12 weeks.
The programme started within ten working days after the
examination. Patients were kept unaware of the study
hypothesis. However, the nature of the study made it
impossible to blind patients and therapists. The assessor
was kept as much as possible unaware of the group
assignment. However, as she worked in this hospital during
the experiment, she saw some patients arriving for training
sessions.
After the 12 week programme patients were encouraged
to continue with the learned exercises during the next
6 months. No other advice or restrictions were provided.
Test description and measures Prior to the clinical exam-
ination, the physiotherapist checked the vibration percep-
tion threshold with the tuning fork. Maximum isometric
strength of the hip, knee, ankle flexors and extensors was
then measured with a hand-held dynamometer (MicroFET;
Hoggan Health Industries, Inc., West Jordan, UT, USA)
[30]. Joint mobility of the hip and both knee and ankle
flexion and extension were measured with a manual
goniometer. Patients’ worry of falling when performing
different activities was assessed with the Falls Efficacy
Scale International (FES-I) [31]. Afterwards patients
underwent the following functional tests:
1. Performance-oriented mobility assessment (POMA)
[32], which scores 16 items (nine for evaluation of
balance, seven for assessment of gait).
2. Outdoor gait assessment [33] recorded with a device
(Physilog; BioAGM, Lausanne, Switzerland). Partici-
pants were asked to walk, wearing four miniature
gyroscopes (ADXRS 250 analogue device) attached to
both shanks and thighs with Velcro straps, on a specific
walkway at their preferred walking speed. The walk-
way consisted of two 50 m tarred pathways, two 50 m
grass pathways and two 20 m cobblestone pathways in
the hospital’s backyard. For this study only the tarred
terrain was evaluated. A detailed description of this gait
assessment has been published elsewhere [33].
3. Dynamic balance test in which participants had to walk
as fast and as precisely as possible on a 5 m beam
(15 cm high, 15 cm wide). Time was measured with a
460 Diabetologia (2010) 53:458–466stopwatch. Patients had one practice trial before the test
started. If a patient had to step off the beam he or she
was allowed to do the test again. In the event that this
patient stepped off the beam again, he or she was asked
to resume the exercise at the stepping off point,
continuing from there to finish the test.
4. Static balance test evaluating postural control by means
of a device (Biodex Balance System; Biodex Medical
Systems, New York, USA) [34]. The level of difficulty
while standing on this platform can be manipulated by
altering the resistance of the platform to deviations. The
balance test is most difficult when the platform
provides the least resistance to tilting and is therefore
the least stable. Each participant stands barefoot on the
platform and performs two different tests (level 8=
easiest level, level 6=a more difficult level). The foot
position was standardised using a pre-formed triangle
(heels together with feet forming an angle of
20 degrees). Patients were instructed to keep their
hands at their sides. For safety purposes they were
permitted to touch handrails, but only to re-establish
balance during extreme postural deviations. Once in
this position, the stability platform was unlocked to
allow motion. The participants were then instructed to
find a position at which they could maintain platform
stability. Each recording lasted for 60 s with a 60 s rest
between each trial. We used a single recording per test
condition and only one attempt per condition to reduce
fatigue [34]. All tests were done at baseline, after the
12 weeks intervention and at 6 months after the
intervention. A balance index was calculated using
the time and deviation (in degrees) of the platform
away from a level position [35].
Treatment description The training took place twice a week
for 60 min over 12 weeks. This intensity was chosen on the
basis of previously developed successful interventions in
pre-frail elderly persons [25, 36–38]. Each session was
conducted in groups (five to eight participants) in order to
promote long-term participation [39]. The programme was
directed by a physiotherapist and an assistant. Four
different physiotherapists and four assistants were trained
to direct the sessions in order to guarantee continuity. A
session consisted of a warm up (5 min), followed by a
circuit training (40 min) including gait and balance
exercises. Each session was composed of a set of ten tasks.
Balance and walking tasks (stance on heel/toes, tandem
stance, one leg stance, different kinds of walking) alternated
with functional strength and endurance exercises (sitting to
standing, walking up and down a slope, stair climbing and
mini hops). Each task was carried out twice for 1 min each
time, and the complexity of the task could be progressively
increased, e.g. changing from stable to unstable surfaces
(wobble board), increasing step height [40]. Sessions were
completed with interactive games (e.g. badminton, obstacle
race in teams) (10 min) and a short feedback session with
suggestions for individual home exercises (5 min). As
currently no specific gait and balance programme is offered
to diabetic patients, the control group received neither
treatment nor specific advice. Both the intervention group
and control group were allowed to continue their usual
leisure activities.
Sample size calculation In previous studies, gait velocity of
diabetic patients was 1.25±0.19 m/s compared with 1.45±
0.14 m/s in a healthy control group [3]. Allowing that
diabetic patients might improve their mean speed from
1.25 m/s to 1.35 m/s, 64 patients were needed to have an
80% probability that the study would detect a treatment
difference at a two sided 5% level of significance. We
assumed a standard deviation of 0.14 of the response
variable. A 10% drop-out rate was hypothesised and
therefore we aimed to include 71 patients in total.
Data analysis Statistical analyses were performed using
SPSS Version 15 for Windows (SPSS, Chicago, IL, USA).
The Student’s t test was used to compare baseline similarity.
Each outcome was analysed by linear regression (i.e.
analysis of covariance). The outcomes at 12 weeks (i.e.
post-treatment) and 6 months were dependent variables.
The intervention allocation was considered to be a
dichotomous independent variable in the analysis. The
baseline values of the outcome measures were incorporated
in the linear regression model as covariates.
To reduce the risk of Type I error, a Bonferroni corrected
alpha level of p=0.0026 (alpha divided by number of tests
per follow-up) was used to determine a significant
difference between groups. However, to allow identification
of areas of interest for future investigations and to reduce
the risk of Type II errors, the results are presented with the
corrected (p=0.0026) and uncorrected (p=0.05) signifi-
cance levels. An intention to treat analysis was performed
and in the event of missing values for any variables, these
values were imputed by means of the last observation
carried forward method.
Results
This clinical trial is closed to recruitment and closed to
follow-up. The flow chart (Fig. 1) provides a detailed
description of drop-outs and loss to follow-up, as well as
the number of participants analysed in each group. Exercise
adherence ranged from 11 to 24 treatments with a median
of 21. Groups were similar at baseline. Descriptive statistics
show patients’ characteristics (Table 1) and illustrate the
Diabetologia (2010) 53:458–466 461improvement of the intervention group in all variables post-
intervention (Electronic supplementary material [ESM]
Table 1; Fig. 2). Two patients developed pain in their
Achilles tendon, obliging us to slow down the progression
for ‘toe walking’ and ‘one leg stance’ exercises. Interven-
tion group participants partially lost their treatment benefit
in the 6 months of follow-up, but their performance level
remained superior to that at baseline.
Control group patient variables all progressively deteri-
orated compared with their baseline performance (ESM
Table 1).
After intervention, the intervention group increased their
habitual walking speed by 0.149 m/s (0.54 km/h; p<0.001)
compared with the control group. In addition, a majority of
secondary outcome variables showed significant between-
group differences (at the Bonferroni corrected significance
level of p<0.0026) in favour of the intervention group.
These outcome variables were: the dynamic balance test
(time to walk over a beam), the POMA test (total score and
sub-scores), the Biodex sway index recorded at level 6, the
FES-I score, the hip and ankle plantar flexor strength, and
hip flexions mobility. After 6 months, the differences in all
these variables remained significant (p<0.0026) except for
the Biodex sway index (p=0.005) and ankle plantar flexor
strength (p=0.217) (ESM Table 1).
Discussion
This study aimed to evaluate the effect of a training
programme, which was based on core components for
successful fall prevention in the elderly [25], on gait and
balance of diabetic patients. Our results confirm that gait
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Received allocated intervention (n=35) 
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Fig. 1 Flow chart with detailed
description of recruitment,
number of drop-outs and
reasons for not continuing. The
flow chart is based on the
CONSORT Statement recom-
mendations in a previous
publication [45]
Table 1 Description of patients’ baseline characteristics
Baseline evaluation Intervention group Control group
Age (years) 63 (7.99) 64 (8.89)
BMI (kg/m
2) 30.46 (6.03) 31.46 (5.25)
Falls in 12 months (n)
a 0.71 (1.07) 0.45 (0.89)
Test with tuning fork
b 3.23 (1.26) 3.32 (1.32)
Height (cm) 166.14 (8.5) 168.56 (8.64)
Weight (kg) 83.62 (16.56) 89.17 (12.33)
Values are mean (SD)
aA fall was defined as an unexpected event in which the participant
comes to rest on the ground, floor or lower level
bScale 0–8
462 Diabetologia (2010) 53:458–466and balance in these patients can be concurrently improved
by a targeted intervention. Patients in the intervention group
increased gait velocity, balance, muscle strength and joint
mobility, and decreased their fear of falling.
However, post intervention evaluation showed no differ-
ence between groups for the primary outcome CVGCT
(ESM Table 1). Possibly the tarred surface was not
challenging enough to fully reveal the gait problems of our
diabetic patients. The CVGCT was relatively low at baseline
(2.75% for control group, 2.6% for intervention group) and
consequently did not improve (decrease) after treatment,
probably due to a floor effect. Step time variability on
smooth and irregular surfaces was recently shown to be most
strongly associated with reduction in step length on an
irregular surface as compared with a smooth surface [41].
Richardson et al. [41] have shown that the greater the
decrease in step length on an irregular surface, the greater
the step time variability on both surfaces, and the greater the
increase in step time variability on the irregular surface.
Thus, analysis on a more challenging surface, e.g. cobble-
stone pathway, which was beyond this paper’sa i m ,m i g h t
have revealed differences between groups.
Despite the above, the degree of improvement achieved
by the intervention group in gait velocity (0.54 km/h or
11.6%) and dynamic balance (time to walk over a beam)
(3.39 s or 34%) was not only significant but also clinically
relevant. A decrease in gait speed of 0.1 m/s in the elderly
has been associated with a 10% decrease in the ability to
perform daily living activities [42]. Balance tests under-
scored our patients’ progress. At baseline our population
scored 23 to 24 of 28 possible points on the POMA. These
values are just within the critical range (19 to 24 points)
that implies a moderate risk of falling [43]. Intervention
group patients passed this moderate risk of falling cut-off
point after the training. In addition, their change of 2.0
points signifies a real improvement considering that effects
greater than 0.8 (with a group size of n=30) reputedly
represent a significant improvement unrelated to chance
fluctuations [43]. The more difficult Biodex balance test
(level 6) also highlighted patients’ progress in postural
control. The sway index decrease of 1.9 at level 6
represents a 31% improvement.
Importantly, all gait and balance variables (except the
Biodex balance test) remained significant at 6-month
follow-up, although some treatment benefit was lost.
Increased hip and ankle strength as well as ankle mobility
may explain the progress in gait velocity and both static and
dynamic balance, although the improvement of ankle dorsal
flexor strength and ankle dorsiflexion mobility just failed to
be significant at the Bonferroni corrected significance level.
These two values further decreased at 6 months, possibly
explaining the regression of gait and balance measures.
Knee flexion mobility showed normal baseline values,
thereby explaining the absence of improvement after
training. We decided not to calculate the post-treatment
group effect on knee and hip extension mobility as none of
the patients had a flexor contracture.
Regarding the FES-I, patients showed a relatively low
level of concern about falling. Perhaps this result reflects
our study population’s relatively good gait function and
functional capacity. Apparently, our participants had mod-
erate diabetes, with on average only minimal neuropathy.
This could have been influenced by the inclusion and
exclusion criteria used and must be considered in the
clinical decision-making process. It may be hypothesised
that patients with more severe diabetic peripheral neurop-
athy or with more impaired functional capacity would
benefit less from training, due to the fact that, from a
functional point of view, the detrimental effects of the
disease are impossible to reverse or compensate. However,
the reverse may also be possible. Patients suffering from
more severe peripheral neuropathy could benefit even more
from a structured exercise regimen, as their condition
provides more scope for improvement. Moreover, even
though balance and gait changes seen in diabetic patients
are probably primarily due to neuropathy, there are other
Fig. 2 Plots illustrating the
baseline difference of (a) gait
speed, (b) CVGCT, (c) POMA
score, (d) time to walk over a
beam, (e) Biodex sway index
(level 6) and (f) fear of falls for
each group at baseline (BA),
after the intervention (PI) and at
the 6-month follow-up (FU).
Values are adjusted mean and
95% CI. White squares and
dotted line, control group; black
circles and continuous line,
intervention group
Diabetologia (2010) 53:458–466 463potential contributors [5]. Gait impairments are also
observed in diabetic patients without clinically detectable
neuropathy [3], raising the question of whether it would be
worthwhile to test a similar, but more intensive programme
on diabetic patients without neuropathy in order to prevent
further aggravation of gait and balance.
All exercises were taught by qualified physiotherapists
and were function-orientated. To boost patient motivation
and enable them to interact with other patients, the
programme was carried out in small groups at the hospital’s
gymnasium. For further discussion of the results, the effect
of our primary outcome was compared with the results of a
meta-analysis evaluating the effect of exercise on gait speed
in the elderly [22]. This meta-analysis reported a success
rate of 57% for exercise training on habitual gait speed. The
overall gait speed change reported was 0.01 m/s compared
with our 0.15 m/s. However, the range of velocity change
was large (−0.2 to 0.34 m/s), which could be due to the
various studies included and the evaluation of populations
with diverse co-morbidities under varied conditions (e.g.
6 m distance compared with a 6 min walk). We further
compared our baseline CVGCT with values reported for
elderly patients. The values of our population (control
group 2.6%, intervention group 2.75%) are between those
reported for elderly non-fallers (2.1%; mean age 76 years)
and those for elderly fallers (3.8%; mean age 82 years) [44],
which was somewhat better than expected. However, this
may be explained by the fact that our population was about
15 years younger than participants in Hausdorff’s trial [44].
Despite the beneficial effect of our programme on gait
speed and balance, its influence on fall frequency in diabetic
patients still needs to be properly assessed. Although the
CVGCT did not improve, our results provide encouraging
data, which justify further studies with larger sample sizes
focusing on fall frequency itself, physical activity level and
quality of life.
Our baseline evaluation contains no information about
patients’ cardiac status, severity of retinopathy, visual
acuity, disease duration, orthostatic hypotension, medica-
tions or other possible factors related to gait and balance
impairments, and to treatment responsiveness. Neverthe-
less, we assume that randomisation balanced these potential
confounders between groups.
The fact that the control group was given no attention at
all may represent a confounder for this study’s results. The
degree to which an improvement depends on personal
attention from the therapists, vs the effect of the actual
exercise regimen, needs to be considered. However, the
positive result on all measured outcomes clearly points to a
beneficial effect due to therapeutic exercise.
Muscle strength was measured with a hand-held dyna-
mometer, which gives a more precise measurement than
manual muscle testing. However, the reliability and
accuracy of the measurement may be limited by the
investigator’s ability to hold the dynamometer stationary
and by the fact that participants may overpower the testers.
We tried to minimise this problem by ensuring that the
same person always carried out the tests. Nevertheless, the
relatively low ratio between ankle plantar flexor and ankle
dorsal flexor strength could indicate an underestimation
of plantar flexor strength. Further investigations should
address this limitation. In addition, not only sagittal but also
frontal plane muscle strength (i.e. hip abductors and
adductors), which is involved in frontal plane stability
during gait, should be evaluated.
Although our study showed positive results, clinicians
should be aware of possible adverse events. Two patients
developed pain in their Achilles tendon, obliging us to slow
down the progression for ‘toe walking’ and ‘one leg stance’
exercises. More moderate progression and a longer warm
up could possibly avoid such incidents.
To the best of our knowledge, this is one of the first
randomised controlled trials to describe an effective physio-
therapy training programme geared to concurrently improv-
ing the balance and gait of diabetic patients. Future studies
should examine the effect of exercise regimens on patient
groups differentiated by neuropathy status (patients without,
with mild or with severe peripheral neuropathy, identified by
a more complex instrument for peripheral neuropathy
screening). In addition, outcomes such as functional capacity,
the number of falls or physical activity level should be
considered in order to draw meaningful conclusions about
exercise efficacy among patients with diabetes, thereby
facilitating medical and clinical decision-making. The ap-
praisal of (1) advantages, difficulties and feasibility of
treatment, and/or (2) prevention of gait and balance problems,
as well as (3) the related fall risk in diabetic patients may be
another interesting issue for further quantitative and qualita-
tive studies.
Conclusion
A specific gait and balance training programme based on a
circuit approach and including gait and balance exercises
combined with function-orientated strengthening can im-
prove gait speed and balance, and increase both muscle
strength and joint mobility of diabetic patients with a
vibration perception threshold ≤4. Further studies with a
larger sample size are needed to explore the influence of
these improvements on the number of reported falls,
patients’ physical activity levels and quality of life.
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